Genetically Modified Organisms. If the project involves the use of gene technology (as defined in the Gene Technology Act 2000), then before the research commences, You must be accredited with the Office of the Gene Technology Regulator. You must ensure that the project has been approved in writing by the Your relevant Biosafety and/or Ethics Committees (or equivalent). You must retain all certificates relating to the above and provide evidence to the ARC if required to do so.
Genetically Modified Organisms. (a) The Company and its Subsidiaries have developed, implemented and are complying globally with quality management practices and procedures intended to prevent the unintended presence of regulated biotech traits in their research and commercial seed materials.
Genetically Modified Organisms. If a Centre involves the use of gene technology (as defined in the Gene Technology Act 2000), then before the proposed research commences, the Administering Organisation must ensure that the research has been approved in writing by the relevant Biosafety and/or Ethics Committees (or equivalent) of the Administering Organisation. The Administering Organisation must retain all certificates relating to the above and will provide evidence to the Scheme Coordinator if required to do so. The Administering Organisation must be accredited with the Office of the Gene Technology Regulator.
Genetically Modified Organisms. You are not insured for liability in connection with genetically modified engineered organisms or material, transgenic seeds or any other products of a similar nature.
Genetically Modified Organisms. If a Project involves the use of gene technology (as defined in the Gene Technology Act 2000), then before the proposed research commences, the Administering Organisation must ensure that the research has been approved in writing by the relevant Biosafety and/or Ethics Committees (or equivalent) of the Administering Organisation. The Administering Organisation must retain all certificates relating to the above and will provide evidence to the ARC if required to do so. The Administering Organisation must be accredited with the Office of the Gene Technology Regulator. Ionising radiation: If a Project involves the use of ionising radiation, the Administering Organisation must ensure that any personnel performing procedures involving ionising radiation are appropriately trained and hold a relevant current licence from the appropriate State authority. The Administering Organisation must retain all such licences and shall provide them to the ARC if required to do so. Social science data sets: Any digital data arising from a Project involving research relating to the social sciences must be lodged with the Australian Data Archive (ADA) or another equivalent repository for secondary use by other investigators. This must normally be done within two years of the conclusion of any fieldwork relating to the research. If a CI is not intending to do so within the two-year period, they must include the reasons in the Final Report.
Genetically Modified Organisms. Working with genetically modified microorganisms (GMM) and organisms (GMO) requires specific facilities and procedures to ensure that both you, your coworkers, and the environment are safe.
Genetically Modified Organisms. If a Project involves the use of gene technology (as defined in the Gene Technology Act 2000), then before the proposed research commences, the Administering Organisation must ensure that the research has been approved in writing by the relevant Biosafety and/or Ethics Committees (or equivalent) of the Administering Organisation. The Administering Organisation must retain all certificates relating to the above and will provide evidence to the ARC if required to do so. The Administering Organisation must be accredited with the Office of the Gene Technology Regulator. Ionising radiation: If a Project involves the use of ionising radiation, the Administering Organisation must ensure that any personnel performing procedures involving ionising radiation are appropriately trained and hold a relevant current licence from the appropriate State authority. The Administering Organisation must retain all such licences and provide them to the ARC if required to do so. Social science data sets: Any digital data arising from a Project involving research relating to the social sciences must be lodged with the Australian Data Archive (ADA) or another equivalent repository for secondary use by other investigators. This must normally be done within two years of the conclusion of any fieldwork relating to the research. If a CI is not intending to do so within the two-year period, they must include the reasons in the Final Report. Australian Antarctic Division: All research projects conducted in the Antarctic, the Subantarctic and the Southern Ocean must comply with all relevant international obligations and national and state legislative requirements regardless of the provider of logistics support. CIs are required to inform the Australian Antarctic Division (AAD) of any Australian traveling to the Antarctic, the Subantarctic or Southern Ocean as part of the project. The AAD will provide advice on the necessary permits, work health and safety requirements, and other steps that need to be taken prior to travel. Further information on the conditions are provided on the AAD website. Schedule A also provides further information regarding travel to the Antarctic, the Subantarctic and the Southern Ocean.
Genetically Modified Organisms. (a) Seller’s quality assurance and stewardship manuals, including manuals for each cotton elite event, that relate to the Stoneville Package are attached hereto as Schedule 5.16(a) (the “Seller Manuals”). Each of the Seller, the Company and DSTC has developed, implemented and is complying globally with quality assurance and stewardship practices and procedures with respect to the Business, including those practices and procedures described in the Seller Manuals, which are intended, among other things, to prevent the unlawful adventitious presence of regulated and deregulated transformation events in its research and commercial cotton seed materials, including the testing of foundation commercial seed materials used in the Business.
Genetically Modified Organisms. (a) Schedule 3.21 sets forth complete details of the procedures performed by or on behalf of Seller or the Company to minimize the possibility of unapproved GMOs existing in any Transferred Germplasm and of assessments made by or on behalf of Seller or the Company as to the effectiveness of such procedures and steps taken to implement such procedures. Seller and the Company have, since the introduction of such procedures, operated in accordance with the terms of such procedures and, other than with respect to ongoing improvements to them, has not deviated from such procedures or failed to implement such procedures in connection with the use by Seller or the Company of any Transferred Germplasm.
